Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
Partnership to Deliver a New Immersive Pokémon Experience, Created in Collaboration with The Pokémon Company International and Slated to Debut in Europe in Spring 2027
Three major European pilgrimage itineraries, certified by the Council of Europe, converge in Lazio on their way to Rome. At the heart of the “Antichi Cammini d'Italia” project.
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Gen......
